Dramatic results with diabetes drug

The glucose-lowering drug liraglutide cuts the combined risk of MI, stroke and death from cardiovascular causes by 13% in type 2 diabetes patients, a global study shows.

The research published in the New England Journal of Medicine also links liraglutide with a 22% lower risk of cardiovascular death, 15% reduced risk of death from any cause and a  22% lower risk of new evidence of advanced kidney disease.

The double